The table below consists of a summary of all indicators that will be measured based on routine reports from stakeholders implementing/supporting HIV/AIDS projects/programs, estimates and/or through record keeping by HAPCO itself. Who is expected to report on which program indicator can be referred from Chapter 6 – HIV/AIDS Indicators’ Reference Pages. Hierarchy and frequency of reporting is described in Chapter 3, Section 3.3 – M&E Reporting Levels and Information Flow. The reporting formats for each program indicator will be included in the M&E Operational Manual and distributed to all stakeholders.
|
|
Behaviour Change Communication (BCC)
|
Prv3
|
Number of teachers trained in life-skills-based HIV/AIDS education and graduated in the last 12 months
|
Condom promotion and distribution
|
Prv7
|
Total number of condoms available for distribution nationwide during the preceding 12 months, divided by the total population aged 15-49 (disaggregated by male/female condoms)
|
Blood safety
|
Prv9
|
Percentage of voluntary, non-remunerated blood donors donating blood in the last 12 months (disaggregated by age, sex and urban/rural)
|
Prv10
|
Number of blood units collected in the last 12 months (disaggregated by region and urban/rural)
|
Prv11
|
Number of blood banks in the country (disaggregated by region and urban/rural)
|
Management of sexually transmitted infections (STIs)
|
Prv15
|
Number of health workers trained on syndromic management of STIs according to national guideline in the last 12 months (disaggregated by region)
|
HIV counseling and testing
|
Prv16
|
Number of individuals receiving HIV counseling and testing in the last 12 months:
(a) Number of individuals who received pre-test counselling,
(b) Percent of those counselled who received HIV testing,
(c) Percent of those tested who were positive,
(d) Percent of those tested who received their results through post-test counselling services, and
(e) Percent of those tested HIV-positive who were referred to care and support services
(disaggregated by type of service (voluntary/diagnostic), age, sex, region and urban/rural)
|
Prevention of mother-to-child transmission (PMTCT)
|
Prv17
|
Percentage of HIV-infected pregnant women receiving a complete course of antiretroviral prophylaxis to reduce the risk of MTCT in accordance with nationally approved treatment protocol in the last 12 months (disaggregated by region)
|
Prv18
|
Percentage of HIV-infected infants born to HIV-infected mothers (disaggregated by region)
|
Prv20
|
Percentage of pregnant women that:
a. Attend at least one ANC visit
b. Attend at least one ANC visit that is a PMTCT site
c. Receive pre-test counseling on HIV
d. Receive testing for HIV
e. Receive post-test counseling on HIV
f. Receive HIV results
|
Prv21
|
Number of health facilities providing PMTCT services in the past 12 months (disaggregated by region)
|
Service availability
|
Prv23
|
Percentage of Woredas with at least one VCT center in the last 12 months (disaggregated by region)
|
Prv24
|
Percentage of Woredas with at least one health facility providing PMTCT (disaggregated by region)
|
Prv25
|
Percentage of Woredas with at leas one health facility providing ART (disaggregated by region)
|
Prv26
|
Number of Regions/Woredas who have established HIV/AIDS resource center
|
Socioeconomic and material support
|
CST2
|
Number of people aged 15-59 who has received help from home-based program in the last 12 months (disaggregated age, sex, region and type and level of support)
|
Clinical care including ARV therapy and TB treatment
|
CST3
|
Percentage of people with advanced HIV infection receiving ARV combination therapy (disaggregated by age, sex, region, and urban/rural)
|
CST7
|
Percentage of designated laboratories with the capacity to monitor ART according to national guidelines
|
Orphans and vulnerable children (OVC)
|
CST9
|
Number of orphans and vulnerable children who received free external support in the last 12 months (disaggregated by age and sex of OVC, region and type and level of free support)
|
Surveillance and research
|
PS3
|
Number of national level HIV/AIDS related researches carried out in the last 12 months
|
PS4
|
Number of National HIV sentinel surveillance sites existing at the time of data collection (disaggregate by region and urban /rural)
|
Monitoring and evaluation
|
PS9
|
Percentage spending for M&E by HAPCO in the last 12 months
|
PS10
|
Proportion of all stakeholders implementing/supporting HIV/AIDS projects/programs that submit timely reports to HAPCO using standard reporting formats
|
Capacity Building
|
PS11
|
Number of National Partnership Forum and Joint Review meetings organized by HAPCO in the last 12 months
|
PS12
|
Number of Regional HAPCOs that have installed CRIS and established an online access with National HAPCO
|
PS13
|
Number of staff at Regional and Woreda level trained on M&E and Project Management by HAPCO in the last 12 months
|
Financial utilization
|
PS14
|
Financial allocation and utilization in the last 12 months (disaggregated by component: BCC, Condom promotion and distribution, etc.)
|
)